Microsoft To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday
Portfolio Pulse from Avi Kapoor
Top Wall Street analysts have updated their price targets and ratings for several major companies. Notable changes include a significant price target cut for SunPower Corporation by Goldman Sachs, an increase in price target for Microsoft Corporation by Piper Sandler, and a decrease in price target for Walgreens Boots Alliance by Barclays.
July 23, 2024 | 1:59 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Deutsche Bank cut the price target for Bristol-Myers Squibb from $53 to $45, maintaining a Hold rating. Shares rose 0.1% to close at $42.67 on Monday.
The price target cut and maintained Hold rating suggest a cautious outlook for Bristol-Myers Squibb. The minimal share price increase indicates a neutral market reaction.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Baird cut the price target for CrowdStrike from $350 to $335, maintaining an Outperform rating. Shares fell 13.5% to close at $263.91 on Monday.
The price target cut and maintained Outperform rating suggest a mixed outlook for CrowdStrike. The significant share price drop indicates a negative market reaction.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Goldman Sachs cut the price target for SunPower Corporation from $2 to $0.5, maintaining a Sell rating. Despite this, SunPower shares gained 5.4% to close at $0.7158 on Monday.
The significant price target cut and maintained Sell rating by Goldman Sachs suggest a negative outlook for SunPower. However, the short-term gain in share price may be due to other market factors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Barclays decreased the price target for Walgreens Boots Alliance from $11 to $7, maintaining an Underweight rating. Shares gained 2.6% to close at $11.30 on Monday.
The significant price target cut and maintained Underweight rating suggest a negative outlook for Walgreens. The share price gain may be due to other market factors.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Piper Sandler increased the price target for Cathay General Bancorp from $32 to $36, maintaining an Underweight rating. Shares gained 2.4% to close at $43.02 on Monday.
The increase in price target suggests a more positive outlook, but the maintained Underweight rating indicates some caution. The share price gain reflects a positive market reaction.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Keefe, Bruyette & Woods boosted the price target for D.R. Horton from $178 to $208, maintaining an Outperform rating. Shares gained 1.9% to close at $177.16 on Monday.
The increased price target and maintained Outperform rating indicate a positive outlook for D.R. Horton. The share price gain reflects a positive market reaction.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Piper Sandler increased the price target for Microsoft from $465 to $485, maintaining an Overweight rating. Shares gained 1.3% to close at $442.94 on Monday.
The increased price target and maintained Overweight rating indicate a positive outlook for Microsoft. The share price gain reflects a positive market reaction.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Baird boosted the price target for QUALCOMM from $200 to $250, maintaining an Outperform rating. Shares gained 4.7% to close at $194.97 on Monday.
The increased price target and maintained Outperform rating indicate a positive outlook for QUALCOMM. The significant share price gain reflects a strong positive market reaction.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
RBC Capital raised the price target for ResMed from $200 to $204, maintaining a Sector Perform rating. Shares gained 2% to close at $207.28 on Monday.
The slight increase in price target suggests a modestly positive outlook, but the maintained Sector Perform rating indicates a neutral stance. The share price gain shows a positive market reaction.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Stephens & Co. raised the price target for Zions Bancorporation from $48 to $51, maintaining an Equal-Weight rating. Shares rose 1% to close at $49.48 on Monday.
The raised price target indicates a slightly more positive outlook, but the Equal-Weight rating suggests a neutral stance. The share price increase shows a modest positive market reaction.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 70